Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Houcine Hamidi

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Seminars in Immunology|May 16, 2025
Harnessing complement biomarkers for precision cancer careHoucine Hamidi, Idris Boudhabhay, Marie-Agnes Dragon-Durey
Immunology Letters|February 9, 2026
Complement involvement in antiphospholipid syndromeHoucine Hamidi, Luc Darnige, Marie-Agnès Dragon Durey
Current Opinion in Immunology|August 7, 2025
Complement in antiphospholipid syndrome, time to target?Marie-Agnès Dragon Durey, Houcine Hamidi, Luc Darnige
European Journal of Immunology|May 3, 2024
Autoantibodies against complement proteins in patients with antiphospholipid syndrome: Prevalence and clinical associationsRémi Philip, Achille Aouba, Nicolas Martin Silva, et al.
Frontiers in Nephrology|July 3, 2025
Case Report: Failure of eculizumab to block complement to prevent relapse of anti-phospholipid syndrome in kidney transplant recipientThibault Laban, Fredéric Pigneur, Constance Guillaud, et al.
Oncoimmunology|March 15, 2024
Humoral complementomics - exploration of noninvasive complement biomarkers as predictors of renal cancer progressionMargot Revel, Mikel Rezola Artero, Houcine Hamidi, et al.
Kidney International Reports|February 23, 2026
Immune Profiling Identifies High-Risk Neutrophil-Rich Subtype in Checkpoint Inhibitor NephritisIdris Boudhabhay, Helene Lazareth, Julie Oniszczuk, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Seminars in Immunology|May 16, 2025
Harnessing complement biomarkers for precision cancer careHoucine Hamidi, Idris Boudhabhay, Marie-Agnes Dragon-Durey
Immunology Letters|February 9, 2026
Complement involvement in antiphospholipid syndromeHoucine Hamidi, Luc Darnige, Marie-Agnès Dragon Durey
Current Opinion in Immunology|August 7, 2025
Complement in antiphospholipid syndrome, time to target?Marie-Agnès Dragon Durey, Houcine Hamidi, Luc Darnige
European Journal of Immunology|May 3, 2024
Autoantibodies against complement proteins in patients with antiphospholipid syndrome: Prevalence and clinical associationsRémi Philip, Achille Aouba, Nicolas Martin Silva, et al.
Frontiers in Nephrology|July 3, 2025
Case Report: Failure of eculizumab to block complement to prevent relapse of anti-phospholipid syndrome in kidney transplant recipientThibault Laban, Fredéric Pigneur, Constance Guillaud, et al.
Oncoimmunology|March 15, 2024
Humoral complementomics - exploration of noninvasive complement biomarkers as predictors of renal cancer progressionMargot Revel, Mikel Rezola Artero, Houcine Hamidi, et al.
Kidney International Reports|February 23, 2026
Immune Profiling Identifies High-Risk Neutrophil-Rich Subtype in Checkpoint Inhibitor NephritisIdris Boudhabhay, Helene Lazareth, Julie Oniszczuk, et al.
Pageof 1